Vital dye staining | |||||
---|---|---|---|---|---|
Study | Location | Year | Study design | Number of eyes | Major findings |
Romero et al. [20] | Brazil | 2013 | Prospective case series | Pterygia (10) Actinic keratosis (10) Conjunctival intraepithelial neoplasia and conjunctival SCC (27) |
Toluidine blue 1% is a good tool for the diagnosis of OSSN and premalignant lesions but the intensity of staining does not correlate with the degree of malignancy (sensitivity 100%, specificity 50%, PPV 73%, and NPV 100%). |
| |||||
Steffen et al. [21] | South Africa | 2014 | Prospective diagnostic validation | Malignant lesions including invasive SCC (16) and severe dysplasia (17) Benign or premalignant lesions (42) |
Methylene blue 1% can exclude malignant lesions but cannot replace histopathology as the gold standard (sensitivity 97%, specificity 50%, PPV 60%, and NPV 95%). |
| |||||
Gichuhi et al. [22] | Kenya | 2015 | Cross-sectional, multicenter | OSSN (143) Non-OSSN (276) |
Toluidine blue 0.05% is a good screening tool but not a good diagnostic tool due to a high frequency of false positives (sensitivity 92%, specificity 31%, PPV 41%, and NPV 88%). |